Prolonged Treatment of Peanut-Allergic Mice with Bortezomib Significantly Reduces Serum Anti-Peanut IgE but Does Not Affect Allergic Symptoms

Publisher： Karger

E-ISSN： 1423-0097|170|4|257-261

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.170, Iss.4, 2016-10, pp. : 257-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of age on IgE response in peanut‐allergic children and adolescents from the Mediterranean area

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 6, 2015-09 ,pp. : 497-502

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characterization of IgE Binding to Lupin, Peanut and Almond with Sera from Lupin-Allergic Patients

By  

International Archives of Allergy and Immunology, Vol. 146, Iss. 4, 2008-03 ,pp. : 267-276

Karger

Access to resources Recommend Favorite

The Safety of Peanut Oral Immunotherapy in Peanut-Allergic Subjects in a Single-Center Trial

By  

International Archives of Allergy and Immunology, Vol. 159, Iss. 2, 2012-06 ,pp. : 179-182

Karger

Access to resources Recommend Favorite

Long-Term Bortezomib Treatment Reduces Allergen-Specific IgE but Fails to Ameliorate Chronic Asthma in Mice

By  

International Archives of Allergy and Immunology, Vol. 158, Iss. 1, 2011-12 ,pp. : 43-53

Karger

Access to resources Recommend Favorite

Relationship between Total Tear and Serum IgE in Allergic Conjunctivitis

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 4, 2010-10 ,pp. : 349-352

Karger

Access to resources Recommend Favorite